Login to Your Account

Other News To Note

Tuesday, July 5, 2011
Vivus Inc., of Mountain View, Calif., submitted a new drug application (NDA) to the FDA for avanafil, its investigational drug for the treatment of erectile dysfunction (ED).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription